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     Because of the huge amounts of proteomic data and demand for new methods of laboratory analysis 
results, proteins collective analysis, in addition to taking less time, biostatistician assist at identification 
of new patterns in the data set. In this study, rat hippocampus proteome in normal and Alzheimer's 
disease (AD) were analyzed by using proteomic techniques and bioinformatics’ analysis. Protein extracts 
from normal and Alzheimer's rats were separated by using two-dimensional electrophoresis (2DE). The 
silver staining method was used for detecting spots. Bioinformatics analysis of proteome were performed 
by progensis same spots software. Bioinformatics and statistical analysis of 2DE gel techniques obtained 
760 protein spots were detected in both normal and AD rats.  Comparisons between controls and 
Alzheimer gel containing 20 common proteins were expressed significantly differences. 16 new proteins 
were expressed in AD, while 36 proteins were suppressed. Proteins clustering by using correlation 
analysis evaluated 3 clusters in the proteome; Principal component analysis also confirmed the results of 
clustering. Finally, we can conclude that a significant expression of Alzheimer changes in the 
hippocampus proteome which are associated with specific biological processes summarized in 3 main 
clusters indicated 3 principal biological pathways of AD. 
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INTRODUCTION 
    Alzheimer’s disease (AD), the most common 
form of dementia, is characterized by intracellular 
accumulation of neurofibrillary tangles (NFT) 
and extracellular beta amyloid (Aβ) plaque [1, 2]. 
Aβ is a toxic pro-inflammatory agent that 
promotes inflammatory process in the brain [3]. 
AD patient Also have defect in cholinergic 
system[4,5]. In AD, hippocampus is the first brain 
region changes, in addition the greatest 
concentration of amyloid plaques [5] are also 
present, so it is detected early neurodegenerative 
symptoms include significant deficits in the 
performance of hippocampus dependent cognitive 
abilities such as spatial learning and memory [6]. 
AD is the result of both genetic and etiologic 
factor (environmental, trauma, and 
immunological changes such as viral invasion 
and inflammation) and changes in the brain may 
start several decades before the onset of clinical 
symptoms. The other side, there is no cure for AD 
so far, and the disease causes progressive decline 
in daily activities, eventually resulting in death 
[7,8]. Different Proteomic investigations by using 
classical and advanced methods on human and 
animal models of Alzheimer's demonstrated 
changes in protein expression in different parts of 
the brain [9-12]. Several classes of proteins 
involved in different stages of the AD such as 
proteins responsible for synaptic transmission 
(synaptosomes proteomics), a set of heat shock 
proteins (HSC71) and mitochondrial proteins 
were expressed in response to oxidative stress 
[11]. As well biomarkers that ways have been 
identified as targets for diagnostic and therapeutic 
proteins include presenilin 1 and 2, and beta 
amyloid precursor (APP) [13] in the first stage 
and the apolipoprotein E allele e4 [14] in the final 
stages as behavioral disorders Alzheimer's genes 
responsible. Mutations in the presenilin genes 
cause of 80% AD development [15]. Because of 
the huge amounts of proteomic data, new analysis 
methods for data mining is necessary so analysis 
of proteins as protein set can also spend less time 
 




and help researchers to identify new patterns in 
the data set. Today, the use of software clustering 
imperative seems to be one of the main ways to 
get quick access to information and analysis of 
experimental data (6). In this study, hippocampus 
tissue proteome of rats in AD and normal groups 
are analyzed by using proteomic techniques and 
bioinformatics analyzes. Increased or decreased 
protein expression of two groups gels are cluster 
by using progensis same spots software. This 
software can cluster protein in different groups 
with co-expression [6] that indicates every cluster 
has biological correlation. Relationships based on 
co-expression capture the overall tendency for a 
pair or group of genes to have similar expression 
levels across conditions (as opposed to being high 
in one set of conditions and low in another)[7]. In 
every disorder, proteomic study employ in the 
area of disease particularly to reveal disease 
relevant biomarkers. Thus, in this study detect 
protein co-expression of rat hippocampus to 
identify biomarkers for molecular diagnosis as 
well as new targets for medical intervention of the 
disease process.  
  
MATERIALS AND METHODS 
Animals 
     A total number of 10 male Wistar rats, 
weighing 220-280 g, were employed in the 
present study. The animals were kept at constant 
temperature under a 12:12 h light/dark cycle with 
free access to food and water. The subjects were 
first divided into control and Alzheimer group.  
Establishment of AD model 
 Animal model of AD was created by 
intracerebroventricular (i.c.v.) injection of 10 g 
of A1-42 peptide (Sigma Aldrich, St. Louis, 
MO, USA) dissolved in distilled water. The 
injection site (AP=Bregma, LR=1.5 mm, D=4 
mm) was determined according to the Stereotaxic 
Atlas (15). The animals in control group were 
treated with the same procedure except that they 
received distilled water. 
Sampling 
 The Congo red staining verified the formation of 
A plaque in the hippocampal area of brain in 
Aβ-treated animals (16, 17). Hippocampus tissue 
samples were taken from both groups of rats for 
proteomics analysis. 
Protein purification 
Fresh tissue samples of hippocampus tissue were 
snap frozen and kept in liquid nitrogen until use. 
Each tissue sample was added to an appropriate 
amount of lysis buffer containing 7 M Urea, 
2 M Thiourea, 4% CHAPS(3-(3-
Cholamidopropyl) dimethylammonio)-1-
propanesulfonic acid), 40 mM Tris, 50 mM DTT 
(Dithiothreitol), and protease inhibitor (one tablet 
in 2 ml lysis buffer) (Roche). Tissue samples 
were homogenized by pestle under ice conditions. 
Homogenates were left for one hour at room 
temperature and sonicated on ice for 10 s every 
15 min. After that centrifuged at 20000 g for 60 
minutes at 4 °C. Protein concentration of all 
samples was estimated using a Bradford based 
microassay. 200 µg from each sample was 
resuspended in rehydration buffer containing 
8 M urea, 4% CHAPS, 0.5% Ampholyte, 
50 mM DTT for 7 hr and then loaded onto 
7 cm immobilized (pH=3-10) nonlinear gradient 
strips (Bio-Rad, Hercules, CA, USA). 
Two dimensional SDS-PAGES  
The first dimension of 2D electrophoresis was 
performed on the PROTEAN IEF Cell system 
(Bio-Rad). Next, gels were equilibrated for 15 
min in equilibration buffer I (6M urea, 2% SDS, 
0.375 M Tris Hcl pH8.8, 20% glycerol, 130mM 
DTT). A 12% SDS-Polyacrylamide slab gel was 
used for the second dimension gel 
electrophoresis. Equilibrated IPG strips were 
placed on the surface of the second dimension 
gels and then sealed with 0.5% agarose in SDS 
electrophoresis buffer (25mM Tris base, 192mM 
glycine, 0.1%SDS) and were run vertically. 
Resulting gels were stained with silver nitrate. 
Bioinformatics analysis 
2DE gels were scanned by Densitometer GS-800 
(BioRad) and gels were analyzed by non linear 
progenesis same spot software to compare gels 
together and compare the spots in one statement 
in gels and get the density of same spot in each of 
gel. Statistical significance achieve by ANOVA 
(P value <0.05). Hierarchical clustering and 
principal component analysis were used for 
comparing two groups.    
 
RESULT 
     In this study two-dimensional gel 
electrophoresis of hippocampus proteome of 
normal and Alzheimeric rat were analysis by 
progenesis same spot software. Figure 1 shows 
2DE gel images of hippocampus proteom in 
normal (A) and Alzheimeric (B) rats. Gel analysis 
with progenesis software identified 760 protein 
spots with different expression. Protein 
expression changes in hippocampus of 
 




alzhiemeric rats compared with the control group 
determine that there are 20 common proteins  
significantly differences expression in both 
groups. 16 new proteins expressed in alzheimeric 
condition while suppressed expression of 36 
proteins. 3D image of some protein spots with 
different expression in both normal and AD 
groups were represented in Figure 2. Software is 
also analyzed protein clustering by using 
correlation analysis to evaluate the relationship 
between expression profiles. Cluster of co-
expression proteins represented as dendrogram 
with vertical distance between pairs of spots 
depicted in Figure 3 that dendrogram represent 
the similarity of expression profiles in both 
groups. To determine the outlier data and confirm 
doing appropriate clustering perform principal 
component analysis on control and AD groups 






Figure 1. 2DE gels of normal (A) and AD (B) rat hippocampus. Proteins were separated on a pH 3-10 NL IPG strips in the first 



































Figure 2. 3D image of protein spots with different expression in two groups  
 
 











Figure 4 (A) - PCA for control group (B) - PCA for AD group 
 
DISCUSSION 
    World's population is getting old and older 
and the medical community face to new 
challenges and complexities of diagnosis and 
treatment of diseases associated with the aging. 
Alzheimer's disease is a common degenerative 
disease of the central nervous system [1]. 
According to the alzheimer's world association, 
more than 35 million people worldwide are 
affected by Alzheimer's. In Iranian population 
 




about 600000 people are suffering from AD 
(18). Accumulation of plaques and tangles in 
the cortical areas of brain, leading to the 
emergence of other Alzheimer's symptoms such 
as lack of orientation, impaired speech and 
difficulty doing working skills. 
Neurofibrillary tangles have toxic effects on 
brain areas involved in learning particularly 
hippocampus and cause inflammation of brain 
tissue [19]. The release of acetylcholinesterase 
from amyloid plaques Also reduces the amount 
of acetylcholine, thus will impair spatial 
memory [16]. In present study, rats were 
investigated on Alzheimer's process by 
proteomics approach. Rat hippocampus 
proteome of Normal and AD are analyzed with 
progenesis same spot software. Figure 1 and 2 
depicted images of 2DE gel of both groups and 
its analysis by software. 760 protein spots 
identified which some of them have increased 
expression and other have decreased expression. 
Comparison between controls and AD gel 
protein contain 20 proteins statistically 
significant differences in their expression in 
both groups. AD expressed 16 new proteins and 
suppressed 36 protein expressions. several 
proteins with change of expression are involved 
in different stages of AD such as the proteins 
responsible for the transmission of synapse, heat 
shock proteins and mitochondrial proteins in 
response to oxidative stress [11] or  AD 
biomarkers like presenilin proteins 1 and 2 , 
beta amyloid precursor (APP) [13] and 
apolipoprotein E allele e4 [14]. Because of 
hyper-phosphorylation of Tau protein, the 
stabilizing effect of forming neural pathways 
become weak and creates slender coils 
Neurofilaments [19]. Recent evidence by Shi X 
et al. reported that four proteins which 
abundance was significantly altered in AD rats 
corresponded to synapsin Ib, protein disulfide-
isomerase A3 precursor, tubulin β chain and 
ATP synthase β subunit [20]. Although, the role 
of plaques and tangles in AD is not fully 
understood, but there is a theory which states 
that amyloid plaques are toxic only indirectly 
compel glial brain cells to produce ROS and 
cytokines to remove or break up the plaques in 
the brains of patients and causes the nerve cells 
to disrupt homeostasis which these created 
inflammation causing destruction neurons and 
emerge symptoms of pathologic disease [21]. In 
this study as represented in Figure 3, alteration 
responsible proteins in AD cluster by 
progenesis same spot software. Cluster analysis 
considered as a shortcut way to discover the 
biomarkers, consists of a heterogeneous 
population divide into the number of 
homogeneous subsets that is called cluster. The 
objective of cluster analysis, finding a group 
that very different with each other, but its 
members are very similar [5, 6]. In this study, as 
depicted in figure 3, there are 3 main protein 
clusters base on the correlation analysis that aid 
in the identification of genes that share similar 
expression patterns across a variety of 
experimental conditions. Genes displaying such 
patterns are often controlled by the same 
transcriptional regulatory program, functionally 
related, or members of the same pathway or 
protein complex. Using unsupervised learning 
(hierarchical clustering) and principal 
component analysis on the mixture parameter 
estimates the samples were distributed into 
groups with similar co-expression patterns. 
Principal component analysis was used to assess 
the reliability of the classification of samples to 
classes. The comparison of the resulting classes 
or groups against the conditions and the 
distribution of samples within group provided 
information on the changes in co-expression 
patterns between conditions [22-24]. So to 
determine any outlier data and confirm 
appropriate clustering, principal component 
analysis for the control and AD groups is shown 
respectively in Figure 4 (a) and (b). Result 
illustrated that there are no outlier in protein set 
of both groups. PCA Analysis represents 
scattering of members of each cluster around a 
vector that the proteins close to each other 
belong to a class, so in this way in proteomics 
can be classified variation among data sets.  On 
the other hand, if the data of the different 
species used can also specify any clusters and 
demonstrate that all instances of a species are 
placed around a vector and all the clusters are 
close together[23]. Several proteomic 
investigations used PCA to classify the protein, 
such as PCA in three-dimensional images of 
proteomic patterns used to detect instances of 
classes in a data set [24-26]. In conclusion, 
there are significant difference in the molecular 
level between control and Alzheimeric groups 
that changes conclude increasing or decreasing 
expression of proteins and the emerge or 
disappearance of proteins. Multivariate 
statistical analyzes such as clustering, principal 
component analysis and correlation analysis 
 




were well revealed these changes and classified 
protein set. More ever to determine the 
molecular mechanisms of AD in rat 
hippocampus needed to clarify the types of 
proteins should be identified by mass 
spectrometry.  
ACKNOWLEDGEMENT 
     This study is derived from Ph.D. thesis of 
Hakimeh Zali. Also this is a research project 
with the code No 1391-1-159-8981 approved by 
the students research committee of Shahid 
Beheshti University of Medical Sciences. 
 
REFERENCES 
1.Korolainen MA, et al. An update on clinical 
proteomics in Alzheimer s research. JOURNAL 
OF NEUROCHEMISTRY. 2010; 112:  1386–
1414. 
2.Vassar R, et al. The Secretase Enzyme BACE 
in Health and Alzheimer’s Disease: Regulation, 
Cell Biology, Function, and Therapeutic  
Potential. The Journal of Neuroscience.  2009; 
29(41):12787–12794. 
3.Richard A Hansen, et al. Functional Outcomes 
of Drug Treatment in Alzheimer's Disease: A 
Systematic Review and Meta-Analysis. Drugs 
& Aging. 2007; 24: 155-167. 
4.Feiqi Zhu and Caiyun Qian, Berberine 
chloride can ameliorate the spatial memory 
impairment and increase the expression of 
interleukin-1beta and inducible nitric oxide 
synthase in the rat model of Alzheimer's 
disease. BMC Neuroscience. 2006; 7:78. 
5.Blasko I, et al. Efficacy of donepezil 
treatment in Alzheimer patients with and 
without subcortical vascular lesions. 
Pharmacology. 2004; 72(1):1-5. 
6. Murzin AG, Brenner SE, Hubbard T, Chothia 
C. A structural   classification of proteins 
database for the investigation of sequences and 
structures. Journal of Molecular Biology. 1995; 
247:536-540. 
7. Orengo CA, Michie AD, Jones S, Jones DT, 
Swindells MB and Thornton JM. CATH  
hierarchic classification of protein domain 
structures. Structure. 1997; 5(8): 1093-1108. 
8.Shen HB, Yang J, Liu XJ, Chou KC. Using 
supervised fuzzy clustering to predict protein 
structural classes. Biochemical and Biophysical 
Research Communications. 2005; 334: 577-581. 
9. Vidal R, et al. Towards a proteome-scale map 
of the human protein–protein interaction 
network. Nature. 2005; 437: 1173-1178. 
10.Vosseller K,  Proteomics of Alzheimer’s 
disease: Unveiling protein  dysregulation in 
complex neuronal systems. Proteomics Clin. 
Appl. 2007; 1: 1351–1361. 
11.Kovacech B, et al. New Age of 
Neuroproteomics in Alzheimer’s Disease 
Research. Cell Mol Neurobiol. 2009; 29:799–
805. 
12.Nilsen J, et al.Estradiol In Vivo Regulation 
of Brain Mitochondrial Proteome. The Journal 
of Neuroscience. 2007; 27(51):14069-14077. 
13.Lahad L, et al. Candidate gene for the 
chromosome 1 familial Alzheimer's disease 
locus. Science. 1995; 269: 973-977.  
14.Thinakaran, G, et al. Identification of the 
role of presenilins beyond Alzheimer's disease. 
Pharmacol. Res. 50:411-418, 2004. 
15. Rocchi A, et al. Causative and susceptibility 
genes for Alzheimer's disease and Parkinson 
disease. Hum Mol Genet. 2003; 12: 3259-3267. 
16.Margita C, et al. Release of acetylcholine 
esterase (AChE) from B-amyloid plaque 
assemblies improves the spatial memory 
impairment in APP-transgenic mice. Chemico-
Biological Interactions. 2008; 175: 142-149. 
17.Soheili Kashani M, Rezaei Tavirani M,  
Talaei SA and Salami M. Aqueous extract of 
lavender (Lavandula angustifolia) improves the 
spatial performance of a rat model of 
Alzheimer’s disease. NEUROSCIENCE 
BULLETIN. 2011; 27(2) : 99-106. 
18.Vepsalainen S. A molecular genetic study 
and expression-based analysis of risk factors of 
Alzheimer's disease. Department of  neurology 
series of reports 90(2007) 
19.Suh YH, et al. Amyloid precursor protein, 
presenilins, and a-synuclein: molecular 
pathogenesis and pharmacological applications 
in Alzheimer's disease. Pharmacol. Rev. 
2002;54:469-525. 
20.Shi X, Lu X, Zhan L, Liu L, Sun M, Gong 
X, Sui H, Niu X, Liu S, Zheng L, Chen J, Zhou 
Y. Rat hippocampal proteomic alterations 
following intrahippocampal injection of 
amyloid beta peptide (1-40). Neurosci 
Lett. 2011; 15;500(2):87-91. 
21.Streit WJ: Microglia and neuroprotection: 
implications for Alzheimer's disease. Brain Res 
Brain Res Rev. 2005; 48:234–239. 
22.Zhou G, Hongmei L, Decamp D. 2d 
differential in-gel electrophoresis for the 
identification of esophageal scans cell cancer-
 




specific protein markers. Molec and Cell 
Proteomics. 2002; 1: 117-23.  
23.Lancashire L, Schmid O, Shah  H and Ball 
G. Classification of bacterial species from 
proteomic data using combinatorial approaches 
incorporating artificial neural networks, cluster 
analysis and principal components analysis.  
Bioinformatics. 2005; 21(10):2191-2199. 
24.Marengo    E, et al. Application of Three-
Way Principal Component Analysis to the 










































Proteomics. Journal of Proteome Research. 
2003; 2 (4): 351–360. 
25.Zali H, Rezaee Ravirani M, Seied Khani 
Nahal A, Moradi S. Application of Non Linear 
Statistics (Principal Component Analysis) in 
Data Analysis of Differentiation Stem Cell to 
Astrocyte. HBI_Journals. 2013; 20 (5) :265-
273. 
26.Zali H, Fakhar H, Rezaee Tavirani M, 
Akbari A. Proteomic Study of Cervical Cancer. 
HBI_Journals. 2013; 20(4):182-191. 
